Article
ABCB1 1199G>A polymorphism (rs2229109) affects the transport of imatinib, nilotinib and dasatinib.
Pharmacogenomics - 1 Jun 2016
Dessilly Géraldine, Elens Laure, Panin Nadtha, Karmani Linda, Demoulin Jean-Baptiste, Haufroid Vincent
Abstract excerpt
AIM: ABCB1 (or P-glycoprotein) is implicated in the multidrug-resistance phenotype, including the resistance toward anticancer drugs such as tyrosine kinase inhibitors (TKIs). The purpose of this study was to evaluate in vitro the influence of the ABCB1 1199G>A SNP on ABCB1 transport activity toward selected TKIs (imatinib, nilotinib and dasatinib) that are currently used in chronic myelogenous leukemia. MATERIAL...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
